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Abstract
Background: Since microvascular and macrovascular complications are reduced through strict glycemic control,
this study carried out to identify the factors that affect glycemic control.
Methods: A cross-sectional design was carried out to examine the role of demographic, anthropometric, clinical
and other relevant characteristics in a sample of 103 female diabetic patients in Tehran, Iran. Personal interviews
were conducted to collect data. Then blood sampling collected and the patients were divided into two outcome
groups (controlled and uncontrolled diabetes). The groups were compared on the basis of their characteristics
using both univariate and multivariate analyses.
Results: In all 103 patients were entered into the study. The mean age of patients was 46.38 (SD = 11.42) years.
Overall, the mean value of HbA1c for the whole sample was 7.5 (SD = 2.35) and 56.3% had HbA1c ≥ 7%. The
findings obtained from univariate analysis revealed that there were no significant differences between controlled
and uncontrolled patients. However, in multivariate analysis the waist circumference was found to be a significant
predictor of increased level of HbA1c (OR = 1.04, 95% CI = 1-1.08, P = 0.04).
Conclusions: The findings suggest that increased level of HbA1c is associated with waist circumference that is a
modifiable factor. It seems that physical activity might be a solution to overcome this health problem. A larger
study to identify other factors also is recommended.
Background
Glycemic control is essential in diabetes management
[1]. Since lower level of blood glucose leads to decreased
rates of morbidity and mortality, maintaining glycemic
control is a goal for all patients with diabetes [2]. Pro-
spective randomized clinical trials and epidemiological
studies have shown that glycemic control is related with
reduced rates of retinopathy, nephropathy, neuropathy
and cardiovascular diseases [1-3]. Glycemic control is
considered as the main therapeutic goal for prevention
of organ damage and other complications of diabetes
[4].
Glycosylated hemoglobin (HbA1C)i st h ep r i m a r yt a r -
get of glycemic control. In this regard, desirable value
for HbA1C is values below 7 [2,3]. HbA1c is a gold stan-
dard in analysis of patients’ status, and is essential to
ensure the optimal care of diabetic patients [5]. HbA1C
is the index that indicates the average blood glucose
during the past 3 months. One percent change in
HbgA1C is equivalent to an approximately 35 mg/dl
change in mean plasma glucose [2,6]. Smaller values of
HbA1C indicate better glycemic control [7]. The
research has shown that with each one percent reduc-
tion in the value of HbA1C, the risk of microvascular
complications is reduced by 40 percent [2].
Despite evidences that strict glycemic control could
reduce microvascular and macrovascular complications
[8-10], a high proportion of patients remain poorly con-
trolled [11]. Achieving optimal glycemic control in clini-
cal practice is difficult and the reasons for its poor
control are complex. A variety of factors are identified
in influencing glycemic control including age, sex, edu-
cation, marital status, BMI, smoking, diabetes duration,
and type of medications [4,12-14]. However, the results
are not consistent and in most instances more than half
of the variance in HbA1c changes are not explained
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factors in Iran, where there are no information on the
topic. We thought this might contribute to existing
knowledge and help to enhance women’s health.
Methods
Design and data collection
A cross-sectional study was carried out to examine the
role of demographic, anthropometric, clinical and other
relevant characteristics in glycemic control among
women attending a diabetes clinic affiliated to the Char-
ity Foundation for Special Diseases (CFFSD), in Tehran,
Iran between November 2008 and July 2009. The inclu-
sion criteria were: aged between 15 to 70 years, being
literate, no history of diabetes complications, and mental
and disabling disorders. To collect data, trained inter-
viewers carried out face-to-face interviews.
Measures
1. Demographic information: this included data on age,
education, marital status, smoking, duration of disease,
and family history of diabetes mellitus
2. Anthropometrics data: this included information on
body mass index (BMI), and waist and hip circumfer-
ence. Trained research personnel measured height and
weight by a Seca 220 (made by Germany) while the sub-
jects were minimally clothed and not wearing Shoes.
The body mass index was calculated based on heights
and weights [BMI = weight (kg)/(height (m))
2]. Based on
the BMI, women were grouped into different categories
as recommended by the WHO: normal range (BMI =
18.5-24.9 kg/m
2), overweight (BMI = 25-29.9 kg/m
2),
and obese (BMI ≥ 30 kg/m
2) [15].
Waist and hip circumference were measured in centi-
meters using a plastic tape meter at the level of the
umbilicus and of the greater trochanters.
3. Clinical measures: this included data on glycosylated
hemoglobin (HbA1C), systolic and diastolic blood pressure,
the presence of dislipidemia, and medication. Glycosylated
hemoglobin was analyzed using immunoturbidometric
assay [16]. Blood pressure was measured with a mercury
sphygmomanometer in a sitting position after 5 minutes
rest.
4. Other relevant data: this included information on
self-monitoring blood glucose (SMBG).
Statistical analysis
Patients were divided into two groups for comparison:
(1) controlled: the HbA1c level less than 7%, (2) uncon-
trolled: the HbA1c level equal or greater than 7% [2,3].
Both univariate and multiple logistic regression analyses
were used to indicate the association between dependent
(controlled vs. uncontrolled diabetes) and independent
variables. Independent variables tested for an association
were age, education, marital status, smoking, body mass
index, waist and hip circumferences, duration of disease,
family history of diabetes mellitus, SMBG, medication
type, systolic and diastolic blood pressure, and the pre-
sence of dislipidemia.
Ethics
The Ethics Committee of Tarbiat Modares University
approved the study. Written informed consent was
obtained from participants after comprehensive explana-
tion of the procedure involved.
Results
In all, 103 patients were entered into the study (45 con-
trolled and 58 uncontrolled diabetes). The mean age of
participants was 46.38 (SD = 11.42), and ranged from 15
to 68 years. The mean for BMI and duration of disease
were 27.7 (SD = 5.04), and 8.55 (SD = 6.10) respectively.
Overall, the mean value of HbA1c for the whole sample
was 7.5 (SD = 2.35) and 56.3% had HbA1c ≥ 7%. The
characteristics of the study sample are presented in
Table 1.
The results obtained from univariate logistic regres-
sion analysis indicated that there were no significant dif-
ferences between controlled and uncontrolled patients.
The results are shown in Table 1. However, when for-
ward conditional multiple logistic regression analysis
was performed, the results showed that waist circumfer-
ence emerged as a significant factor for increased level
of HbA1c (OR = 1.04, 95% CI = 1-1.08, P = 0.04).
Discussion
This was the first study to examine the association
between glycemic control and demographic, anthropo-
metric, clinical and other relevant data in a sample of
Iranian females with diabetes. Overall the proportion of
patients with poor glycemic control was high (56.3%),
and controlled and uncontrolled patients did not differ
significantly with respect to age, education, marital sta-
tus, smoking, duration of disease, family history of dia-
betes mellitus, SMBG, medication, systolic and diastolic
blood pressure, waist and hip circumferences and the
presence of dislipidemia. However, the association
between increased level of HbA1c and variables studied
were in the expected directions (Table 1).
The results obtained from multivariate logistic regres-
sion analysis indicated that the differences between
patients who gained control and those who did not were
due to waist circumference (OR = 1.04). Similarly
Yoshida and Okosun argued that physiologic factors are
important in diabetes control where they have showed
the association between glycemic control and waist cir-
cumference [17,18]. However, Hartz et al. suggested that
patient factors such as understanding of diabetes and
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gic factors are primary important factors on gaining
control over glycosylated hemoglobin [12].
Any modifiable factors that influence glycemic control
could be important [19]. In present study waist
circumference was a predictor of increased level of
HbA1c and thus it is the only modifiable factor in this
regard. Waist circumference is often used as a proxy
measure of abdominal adipose tissue, in particular, visc-
eral adipose tissue (VAT) in clinical settings. VAT has
Table 1 The results obtained from univariate logistic regression analysis for increased level of HbA1c
Controlled diabetes (n = 45,
HbA1c < 7)
Uncontrolled diabetes (n = 58,
HbA1c ≥ 7)
No (%) No (%) OR (95% CI) P-value
Age (year; Mean, SD) 45.3 (10.98) 46.84 (12.48) 1.01 (0.98-1.04) 0.51
Education
Higher 9 (20) 7 (12.1) 1.0 (ref.)
Secondary 29 (64.4) 40 (69) 1.77 (0.59-5.31) 0.31
Primary 7 (15.6) 11 (19) 2.02 (0.51-7.94) 0.31
Marital status
Married 38 (84.4) 44 (75.9) 1.0 (ref.)
Single 4 (8.9) 7 (12.1) 1.51 (0.41-5.56) 0.53
Widowed/divorced 3 (6.7) 7 (12.1) 2.01 (0.49-8.34) 0.33
Smoking
No 41 (91.1) 52 (89.7) 1.0 (ref.)
Yes 4 (8.9) 6 (10.3) 1.18 (0.31-4.47) 0.80
Body Mass Index (kg/m
2)
< 25 19 (43.2) 16 (27.6) 1.0 (ref.)
25-30 15 (34.1) 22 (37.9) 1.74 (0.68-4.43) 0.24
> 30 10 (22.7) 20 (34.5) 2.37 (0.87-6.52) 0.09
Family history of diabetes
Yes 36 (80) 44 (75.9) 1.0 (ref.)
No 9 (20) 14 (24.1) 1.27 (0.49-3.28) 0.62
SMBG
Yes 32 (71.1) 37 (63.8) 1.0 (ref.)
No 13 (28.9) 21 (36.2) 1.40 (0.60-3.23) 0.43
Medication type
None 4 (8.9) 1 (1.7) 1.0 (ref.)
Insulin alone 10 (22.2) 6 (10.3) 2.40 (0.21-26.82) 0.47
Tablet and insulin 5 (11.1) 7 (12.1) 5.60 (0.47-66.45) 0.17
Tablet alone 26 (57.8) 44 (75.9) 6.77 (0.72-63.86) 0.09
Dislipidemia
No 22 (50) 31 (53.4) 1.0 (ref.)
Yes 22 (50) 27 (46.6) 0.87 (0.40-1.91) 0.73
Duration of disease
(year; Mean, SD)
8.66 (6.49) 8.76 (5.74) 1.003 (0.94-1.07) 0.93
Systolic Blood pressure (mmHg;
Mean, SD)
119.67 (17.63) 122.07 (16.33) 1.01 (0.98-1.03) 0.47
Diastolic Blood pressure (mmHg;
Mean, SD)
76.11 (11.12) 77.33 (8.39) 1.01 (0.97-1.06) 0.52
Waist circumference
(Cm; Mean, SD)
85.52 (11.24) 89.44 (10.24) 1.03 (0.1-1.07) 0.07
Hip circumference
(Cm; Mean, SD)
101.65 (10.71) 103.92 (9.19) 1.02 (0.98-1.07) 0.25
CI: Confidence Interval
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obesity related disorders than subcutaneous adipose tis-
sue (SAT) [20-23]. Obesity should be considered as a
chronic disease with multi-factorial etiology, and treat-
ment must be maintained for life-first with lifestyle
interventions (energy-reduced diet and increased physi-
cal activity) and then with pharmacologic approaches,
when necessary [24].
Although other studies found a significant relation-
ship between age [25-27], BMI [26], smoking [26,28],
duration of diabetes [4,27,29], and HbA1c, this study
did not show such associations. However, our findings
on relationship between duration of diabetes, and medi-
cation and HbA1c level was similar to the findings by
Goudswaard et al. and Hartz et al., respectively [13,12].
The findings from this study might be influenced by sev-
eral limitations. The sample size was small making it diffi-
cult to generalize the findings. Secondly, patients were
female and recruited from a single institute rather than
being a community-based sample. Thus the findings could
not be generalized beyond this study sample. Finally most
measures in this study were self-reported and therefore
the possibility of recall bias should not be neglected.
Conclusions
The findings suggest that increased level of HbA1c is
associated with waist circumference that is a modifiable
factor. It seems that physical activity might be a solution
to overcome this health problem. A larger study to iden-
tify other factors also is recommended.
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